Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$909K Sell
9,699
-1,091
-10% -$226K 0.12% 139
2026
Q1
$2.42M Buy
10,790
+2,539
+31% +$633K 0.32% 81
2025
Q4
$1.99M Sell
8,251
-550
-6% -$141K 0.24% 103
2025
Q3
$2.41M Sell
8,801
-1,831
-17% -$500K 0.29% 86
2025
Q2
$2.74M Sell
10,632
-1,159
-10% -$276K 0.31% 89
2025
Q1
$2.64M Hold
11,791
0.29% 94
2024
Q4
$2.7M Sell
11,791
-1,532
-11% -$369K 0.28% 92
2024
Q3
$2.05M Hold
13,323
0.22% 117
2024
Q2
$2.55M Buy
+13,323
New +$2.7M 0.25% 110

Other funds holding RMD

BDF Gestion's RMD Position: Q2 2026 in Review

BDF Gestion reduced its ResMed (RMD) stake by 10% in Q2 2026, selling an estimated $226K and leaving 9,699 shares worth $909K. The position accounts for 0.12% of the portfolio, ranked #139.

BDF Gestion first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.74M in Q2 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • BDF Gestion held 9,699 shares of ResMed worth $909K as of Q2 2026.
  • BDF Gestion sold 1,091 ResMed shares in Q2 2026, an estimated $226K.
  • ResMed made up 0.12% of BDF Gestion's portfolio in Q2 2026, its #139 holding.
  • BDF Gestion first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
  • BDF Gestion's ResMed position peaked at $2.74M in Q2 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on BDF Gestion's 13F filing for Q2 2026, filed 7 Jul 2026.